Related Experiment Video
Updated: Jul 29, 2026

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
Published on: August 18, 2023
[Functional constipation: prospective study and treatment response]
C Martínez-Costa1, M J Palao Ortuño, B Alfaro Ponce
1Servicio de Pediatría, Hospital Clínico, Universidad de Valencia, España. ceciliam@comv.es
Insights
Functional constipation (FC) affects 13% of pediatric consultations, with encopresis in 31%. Treatment success in children with FC depends on regular toilet habits, dietary changes, and family support.
Area of Science:
- Pediatric Gastroenterology
- Child Health
- Digestive Disorders
Background:
- Functional constipation (FC) is a common pediatric condition.
- Understanding its prevalence, contributing factors, and treatment outcomes is crucial for effective management.
Purpose of the Study:
- To determine the prevalence of functional constipation (FC) in children, with or without encopresis.
- To identify factors contributing to the onset of FC.
- To evaluate the treatment response for FC in pediatric patients.
Main Methods:
- A prospective study involving 62 children diagnosed with FC.
- Utilized standard questionnaires for onset age, toilet habits, encopresis, diet, and psychosocial factors.
- Physical assessment and anthropometry were performed; treatment involved demystification, behavioral modification, mineral oil, and senna.
Main Results:
- FC represented 13% of initial pediatric consultations, with a mean age of diagnosis at 6.1 years.
- Common symptoms included painful defecation (60%), rectorrhagia (42%), and obstructive episodes (34%).
- Encopresis was present in 31% of patients; 60% had deficient fiber intake.
Conclusions:
- Successful treatment of FC in children is strongly linked to establishing regular toilet habits, implementing dietary modifications, and fostering positive family attitudes.
- Treatment efficacy improved over time, with 85% achieving satisfactory results within 6-12 months.
- Early intervention and a multidisciplinary approach are key to managing pediatric functional constipation.
Objective:
To assess the prevalence of functional constipation (FC) with and without encopresis, the factors involved in its onset, and treatment response.
Patients And Methods:
A prospective study of 62 children was performed using a standard questionnaire (onset-age, regular toilet use, encopresis, complications, dietary habits and environmental and psychological factors) and physical and anthropometric assessment. FC was defined as a stool frequency of less than 3 bowel movements/week, with passage of large or scybalous stools, with or without 2 or more soiling episodes per week, without underlying disease. Treatment included demystification, behavioral modification and drugs (mineral oil and senna). Each child was periodically re-evaluated, and treatment was considered successful when the defecation rate was 3 or more bowel movements/week, discomfort was absent, and fecal soiling frequency was 2 or fewer episodes/ month.
Results And Conclusions:
FC accounted for 13 % of all first consultations (60 % boys, 40 % girls; mean age at diagnosis 6.1 years). The most frequent manifestations were painful defecation (60 %), rectorrhagia (42 %), obstructive episodes (34 %) and anal fissure or hemorrhoids (17 %); 19 patients (31 %) had encopresis. Nutritional assessment revealed that 84 % of the patients was well nourished and 16 % was overweight. Fiber intake was deficient in more than 60 %. Sixteen (26 %) patients underwent successful relief of impaction with senna (20-30 mg/dose) combined with mineral oil. Maintenance treatment included mineral oil (15-30 ml/day) and senna at the minimum effective dose (5-15 mg/day). Satisfactory results were achieved 1 month later in 32 % of the children, 3-6 months later in 71 %, and 6-12 months later in 85 %; successful response was closely related to regular toilet habits, dietary modification and a shift in the family's attitude.
Related Concept Videos
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS
Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and solid...
